Xtant Medical Holdings (XTNT) Finished Goods (2019 - 2025)

Xtant Medical Holdings (XTNT) has 7 years of Finished Goods data on file, last reported at $19.8 million in Q4 2025.

• Finished Goods for Q4 2025 came in at $19.8 million, down 32.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.8 million (down 32.28% YoY), and the FY2025 annual result was $19.8 million, down 32.28% from the prior year.
• Finished Goods retreated to $19.8 million in Q4 2025 per XTNT's latest filing, from $30.6 million in the prior quarter.
• Over five years, Finished Goods peaked at $31.9 million in Q3 2024 and troughed at $10.6 million in Q2 2022.
• A 5-year average of $20.6 million and a median of $18.1 million in 2021 frame the typical range for Finished Goods.
• The sharpest annual moves came in 2024 and 2025: Finished Goods surged 158.62% in 2024, then plunged 32.28% in 2025.
• A 5-year view of Finished Goods shows it stood at $11.8 million in 2021, then fell by 7.67% to $10.9 million in 2022, then jumped by 158.35% to $28.1 million in 2023, then climbed by 4.08% to $29.2 million in 2024, then sank by 32.28% to $19.8 million in 2025.
• Business Quant data shows XTNT's Finished Goods at $19.8 million in Q4 2025, $30.6 million in Q3 2025, and $31.2 million in Q2 2025.